Lyell Wealth Management, LP Eli Lilly & CO Transaction History

Lyell Wealth Management, LP

$978 Million
Q1 2024

A detailed history of Lyell Wealth Management, LP transactions in Eli Lilly & CO stock. As of the latest transaction made, Lyell Wealth Management, LP holds 2,463 shares of LLY stock, worth $2.31 Million. This represents 0.2% of its overall portfolio holdings.

Number of Shares

2,463

Previous 2,431 1.32%

Holding current value

$2.31 Million

Previous $1.42 Million 35.22%

% of portfolio

0.2%

Previous 0.16%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 03, 2024	BUY	$592.2 - $792.28 $18,950 - $25,352	32 Added 1.32%	2,463 $1.92 Million
Q4 2023 Feb 02, 2024	BUY	$525.19 - $619.13 $6,827 - $8,048	13 Added 0.54%	2,431 $1.42 Million
Q2 2023 Aug 04, 2023	SELL	$350.74 - $468.98 $62,431 - $83,478	-178 Reduced 6.86%	2,418 $1.13 Million
Q1 2023 May 03, 2023	SELL	$310.63 - $364.82 $37,586 - $44,143	-121 Reduced 4.45%	2,596 $891,000
Q4 2022 Jan 24, 2023	BUY	$321.55 - $374.67 $4,501 - $5,245	14 Added 0.52%	2,717 $0

Q3 2022 Oct 24, 2022	SELL	$296.48 - $337.87 $22,236 - $25,340	-75 Reduced 2.7%	2,703 $874,000
Q2 2022 Jul 28, 2022	BUY	$278.73 - $327.27 $16,445 - $19,308	59 Added 2.17%	2,778 $901,000
Q1 2022 May 04, 2022	BUY	$234.69 - $291.66 $33,795 - $41,999	144 Added 5.59%	2,719 $779,000
Q4 2021 Feb 08, 2022	BUY	$224.85 - $279.04 $4,272 - $5,301	19 Added 0.74%	2,575 $711,000
Q3 2021 Nov 10, 2021	SELL	$221.6 - $272.71 $2,437 - $2,999	-11 Reduced 0.43%	2,556 $591,000
Q2 2021 Aug 09, 2021	BUY	$180.55 - $233.54 $59,220 - $76,601	328 Added 14.65%	2,567 $589,000
Q1 2021 May 07, 2021	SELL	$164.32 - $212.72 $28,756 - $37,226	-175 Reduced 7.25%	2,239 $418,000
Q4 2020 Feb 04, 2021	BUY	$130.46 - $172.63 $2,348 - $3,107	18 Added 0.75%	2,414 $408,000
Q3 2020 Nov 04, 2020	BUY	$146.22 - $169.13 $41,818 - $48,371	286 Added 13.55%	2,396 $355,000
Q2 2020 Jul 30, 2020	SELL	$136.42 - $164.18 $13,641 - $16,418	-100 Reduced 4.52%	2,110 $346,000
Q4 2019 Feb 05, 2020	SELL	$106.92 - $132.43 $68,428 - $84,755	-640 Reduced 22.46%	2,210 $290,000
Q2 2019 Aug 01, 2019	SELL	$110.79 - $129.32 $73,675 - $85,997	-665 Reduced 18.92%	2,850 $316,000
Q4 2018 Feb 11, 2019	SELL	$105.9 - $118.64 $6,354 - $7,118	-60 Reduced 1.68%	3,515 $407,000
Q3 2018 Oct 30, 2018	SELL	$85.86 - $107.31 $21,465 - $26,827	-250 Reduced 6.54%	3,575 $384,000
Q2 2018 Jul 30, 2018	BUY	$75.7 - $86.88 $1,362 - $1,563	18 Added 0.47%	3,825 $326,000
Q4 2017 Jan 30, 2018	SELL	$81.94 - $87.89 $33,513 - $35,947	-409 Reduced 9.7%	3,807 $322,000
Q3 2017 Oct 26, 2017	BUY	$77.07 - $85.54 $324,927 - $360,636	4,216	4,216 $361,000

Others Institutions Holding LLY

# of Institutions

3,728

Shares Held

738M

Call Options Held

7.09M

Put Options Held

7.24M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $893B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lyell Wealth Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Lyell Wealth Management, LP with notifications on news.

Account

Lyell Wealth Management, LP Eli Lilly & CO Transaction History